• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G蛋白偶联受体(GPCR)二聚体变构调节中受体-受体相互作用的结构表征

Structural Characterization of Receptor-Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers.

作者信息

Lazim Raudah, Suh Donghyuk, Lee Jai Woo, Vu Thi Ngoc Lan, Yoon Sanghee, Choi Sun

机构信息

Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Korea.

出版信息

Int J Mol Sci. 2021 Mar 22;22(6):3241. doi: 10.3390/ijms22063241.

DOI:10.3390/ijms22063241
PMID:33810175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8005122/
Abstract

G protein-coupled receptor (GPCR) oligomerization, while contentious, continues to attract the attention of researchers. Numerous experimental investigations have validated the presence of GPCR dimers, and the relevance of dimerization in the effectuation of physiological functions intensifies the attractiveness of this concept as a potential therapeutic target. GPCRs, as a single entity, have been the main source of scrutiny for drug design objectives for multiple diseases such as cancer, inflammation, cardiac, and respiratory diseases. The existence of dimers broadens the research scope of GPCR functions, revealing new signaling pathways that can be targeted for disease pathogenesis that have not previously been reported when GPCRs were only viewed in their monomeric form. This review will highlight several aspects of GPCR dimerization, which include a summary of the structural elucidation of the allosteric modulation of class C GPCR activation offered through recent solutions to the three-dimensional, full-length structures of metabotropic glutamate receptor and γ-aminobutyric acid B receptor as well as the role of dimerization in the modification of GPCR function and allostery. With the growing influence of computational methods in the study of GPCRs, we will also be reviewing recent computational tools that have been utilized to map protein-protein interactions (PPI).

摘要

G蛋白偶联受体(GPCR)的寡聚化虽然存在争议,但仍继续吸引着研究人员的关注。众多实验研究已证实GPCR二聚体的存在,并且二聚化在生理功能实现中的相关性增强了这一概念作为潜在治疗靶点的吸引力。GPCR作为单一实体,一直是针对多种疾病(如癌症、炎症、心脏和呼吸系统疾病)进行药物设计目标研究的主要对象。二聚体的存在拓宽了GPCR功能的研究范围,揭示了新的信号通路,这些通路可成为疾病发病机制的靶点,而当GPCR仅以单体形式被看待时,此前并未有相关报道。本综述将重点介绍GPCR二聚化的几个方面,包括通过代谢型谷氨酸受体和γ-氨基丁酸B受体的三维全长结构的最新解析,对C类GPCR激活的变构调节的结构阐释总结,以及二聚化在GPCR功能和变构调节修饰中的作用。随着计算方法在GPCR研究中的影响力不断增加,我们还将回顾最近用于绘制蛋白质-蛋白质相互作用(PPI)的计算工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/24a3990aeca6/ijms-22-03241-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/e1f326ddaed3/ijms-22-03241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/5e95772016da/ijms-22-03241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/96d2b58b047e/ijms-22-03241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/eba6b4fe89c0/ijms-22-03241-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/24a3990aeca6/ijms-22-03241-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/e1f326ddaed3/ijms-22-03241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/5e95772016da/ijms-22-03241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/96d2b58b047e/ijms-22-03241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/eba6b4fe89c0/ijms-22-03241-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6df/8005122/24a3990aeca6/ijms-22-03241-g005.jpg

相似文献

1
Structural Characterization of Receptor-Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers.G蛋白偶联受体(GPCR)二聚体变构调节中受体-受体相互作用的结构表征
Int J Mol Sci. 2021 Mar 22;22(6):3241. doi: 10.3390/ijms22063241.
2
GPCR interaction as a possible way for allosteric control between receptors.G 蛋白偶联受体相互作用作为受体间变构调控的一种可能方式。
Mol Cell Endocrinol. 2019 Apr 15;486:89-95. doi: 10.1016/j.mce.2019.02.019. Epub 2019 Mar 5.
3
Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.G蛋白偶联受体寡聚化的变构抑制:药物开发的策略与挑战
Curr Top Med Chem. 2014;14(15):1842-63. doi: 10.2174/1568026614666140901130843.
4
Peptide recognition, signaling and modulation of class B G protein-coupled receptors.B 类 G 蛋白偶联受体的肽识别、信号转导和调节。
Curr Opin Struct Biol. 2018 Aug;51:53-60. doi: 10.1016/j.sbi.2018.03.008. Epub 2018 Mar 19.
5
Structural Studies of G Protein-Coupled Receptors.G蛋白偶联受体的结构研究
Mol Cells. 2015 Oct;38(10):836-42. doi: 10.14348/molcells.2015.0263. Epub 2015 Oct 15.
6
G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.G蛋白偶联受体寡聚化再探讨:功能与药理学视角
Pharmacol Rev. 2014 Feb 10;66(2):413-34. doi: 10.1124/pr.113.008052. Print 2014.
7
Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors.变构机制中的信号传导:G蛋白偶联受体内的信号传递途径
Molecules. 2017 Jul 15;22(7):1188. doi: 10.3390/molecules22071188.
8
Oligomerization of GPCRs involved in endocrine regulation.参与内分泌调节的G蛋白偶联受体的寡聚化。
J Mol Endocrinol. 2016 Jul;57(1):R59-80. doi: 10.1530/JME-16-0049. Epub 2016 May 5.
9
Asymmetry of GPCR oligomers supports their functional relevance.GPCR 寡聚体的不对称性支持其功能相关性。
Trends Pharmacol Sci. 2011 Sep;32(9):514-20. doi: 10.1016/j.tips.2011.05.006. Epub 2011 Jun 28.
10
Prediction and targeting of GPCR oligomer interfaces.GPCR 寡聚体界面的预测和靶向。
Prog Mol Biol Transl Sci. 2020;169:105-149. doi: 10.1016/bs.pmbts.2019.11.007. Epub 2020 Jan 6.

引用本文的文献

1
Allosteric regulation of L-lactate dehydrogenase: Beyond effector-mediated tetramerization.L-乳酸脱氢酶的变构调节:超越效应物介导的四聚化
Protein Sci. 2025 Jul;34(7):e70206. doi: 10.1002/pro.70206.
2
Inhibitory effect of truncated isoforms on GPCR dimerization predicted by combinatorial computational strategy.通过组合计算策略预测截短亚型对G蛋白偶联受体二聚化的抑制作用。
Comput Struct Biotechnol J. 2023 Dec 9;23:278-286. doi: 10.1016/j.csbj.2023.12.008. eCollection 2024 Dec.
3
Combined treatment with Sigma1R and A2AR agonists fails to inhibit cocaine self-administration despite causing strong antagonistic accumbal A2AR-D2R complex interactions: the potential role of astrocytes.

本文引用的文献

1
Combined 5-HT and mGlu modulation for the treatment of dyskinesia and psychosis in Parkinson's disease.联合 5-HT 和 mGlu 调节治疗帕金森病运动障碍和精神病。
Neuropharmacology. 2021 Mar 15;186:108465. doi: 10.1016/j.neuropharm.2021.108465. Epub 2021 Jan 22.
2
Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors.异源二聚体 mGlu1/5 受体的对称信号转导和负变构调节。
Neuropharmacology. 2021 Jun 1;190:108426. doi: 10.1016/j.neuropharm.2020.108426. Epub 2020 Dec 3.
3
Interclass GPCR heteromerization affects localization and trafficking.
尽管Sigma1R和A2AR激动剂联合治疗会引起伏隔核中强烈的A2AR-D2R复合物拮抗相互作用,但仍无法抑制可卡因自我给药:星形胶质细胞的潜在作用。
Front Mol Neurosci. 2023 May 24;16:1106765. doi: 10.3389/fnmol.2023.1106765. eCollection 2023.
4
Class A and C GPCR Dimers in Neurodegenerative Diseases.A 类和 C 类 G 蛋白偶联受体二聚体在神经退行性疾病中的作用。
Curr Neuropharmacol. 2022;20(11):2081-2141. doi: 10.2174/1570159X20666220327221830.
5
Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.新型双价配体通过靶向假定的μ阿片受体和趋化因子受体 CXCR4 异二聚体发挥潜在的抗伤害作用。
Bioorg Chem. 2022 Mar;120:105641. doi: 10.1016/j.bioorg.2022.105641. Epub 2022 Jan 24.
类间 G 蛋白偶联受体异源二聚体影响定位和转运。
Sci Signal. 2020 Oct 20;13(654):eaaw3122. doi: 10.1126/scisignal.aaw3122.
4
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.近年来,蛋白质-蛋白质相互作用调节剂的研发取得了进展:作用机制和临床试验。
Signal Transduct Target Ther. 2020 Sep 23;5(1):213. doi: 10.1038/s41392-020-00315-3.
5
Advances in Molecular Dynamics Simulations and Enhanced Sampling Methods for the Study of Protein Systems.分子动力学模拟的进展和增强采样方法在蛋白质体系研究中的应用。
Int J Mol Sci. 2020 Sep 1;21(17):6339. doi: 10.3390/ijms21176339.
6
Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.C 类 G 蛋白偶联受体功能的结构和生物物理机制。
Trends Biochem Sci. 2020 Dec;45(12):1049-1064. doi: 10.1016/j.tibs.2020.07.008. Epub 2020 Aug 26.
7
Structure of human GABA receptor in an inactive state.处于非活性状态的人类γ-氨基丁酸(GABA)受体结构。
Nature. 2020 Aug;584(7820):304-309. doi: 10.1038/s41586-020-2452-0. Epub 2020 Jun 24.
8
Structures of metabotropic GABA receptor.代谢型GABA受体的结构
Nature. 2020 Aug;584(7820):310-314. doi: 10.1038/s41586-020-2469-4. Epub 2020 Jun 24.
9
Structural basis of the activation of a metabotropic GABA receptor.代谢型γ-氨基丁酸受体激活的结构基础
Nature. 2020 Aug;584(7820):298-303. doi: 10.1038/s41586-020-2408-4. Epub 2020 Jun 17.
10
FLIM-FRET-Based Structural Characterization of a Class-A GPCR Dimer in the Cell Membrane.基于 FLIM-FRET 的细胞膜上 A 类 G 蛋白偶联受体二聚体的结构特征分析。
J Mol Biol. 2020 Jul 24;432(16):4596-4611. doi: 10.1016/j.jmb.2020.06.009. Epub 2020 Jun 15.